Drugs currently under investigation for the treatment of invasive candidiasis.

about

Containment strategies to address the expanding threat of multidrug-resistant Candida auris.Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets.

P2860

Q50128552-57496565-B67B-47D3-8FF6-6EC764F6F08B Q51149054-16F22B4A-B759-4A33-909E-12415EBC8608

P2860

Drugs currently under investigation for the treatment of invasive candidiasis.

Item

http://www.wikidata.org/entity/Q39375330

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Drugs currently under investigation for the treatment of invasive candidiasis.

@en

Drugs currently under investigation for the treatment of invasive candidiasis.

@nl

type

Item

label

Drugs currently under investigation for the treatment of invasive candidiasis.

@en

Drugs currently under investigation for the treatment of invasive candidiasis.

@nl

prefLabel

Drugs currently under investigation for the treatment of invasive candidiasis.

@en

Drugs currently under investigation for the treatment of invasive candidiasis.

@nl

P1476

Drugs currently under investigation for the treatment of invasive candidiasis.

@en

P2093

Matthew W McCarthy

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Screening of the 'Pathogen Box' identifies an approved pesticide with major anthelmintic activity against the barber's pole worm

Emerging drugs and vaccines for candidemia

Structural and Functional Characterization of NikO, an Enolpyruvyl Transferase Essential in Nikkomycin Biosynthesis

PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90

Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01

Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species

Echinocandin antifungal drugs

Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.

In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection.

Novel nikkomycin analogues generated by mutasynthesis in Streptomyces ansochromogenes

P304

825-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1341488

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28617137

http://www.w3.org/2001/XMLSchema#string

Drugs currently under investigation for the treatment of invasive candidiasis.

about

P2860

P2860

Drugs currently under investigation for the treatment of invasive candidiasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698